Public interest has recently turned to the human eye and the Pfizer COVID-19 Vaccine. Two peer-reviewed papers have helped ...

Pfizer Inc said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against the pandemic.

LOS ANGELES -- The COVID-19 vaccines made by Pfizer and Moderna both require two doses to be administered, several weeks apart, for them to be fully effective. But there has been some scientific ...

Israel's swift vaccination rollout has made it the largest real-world study of Pfizer Inc's COVID-19 vaccine. Results are ...

The Pfizer Covid vaccine increased the risk of heart problems for children sixfold in the first week of having the jab but led to fewer cases in the long term, research suggests.

The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical ...

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump ...

Pfizer’s buyout bid for Metsera was deemed inferior to the latest bid from Novo Nordisk, putting the original agreement in ...

Vaccine advisers to the US Food and Drug Administration voted 17-0 with one abstention Tuesday to recommend Pfizer's COVID-19 vaccine in children 5 to 11. Members of the FDA's Vaccines and Related ...

The sales of Pfizer’s Comirnaty shots sank 25% after the U.S. government narrowed recommendations of who needs the jab ...

Moderna lowered the top end of its 2025 revenue forecast by $200 million on Thursday, citing weaker-than-expected sales of ...

Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...